Type III-A CRISPR immunity promotes mutagenesis of staphylococci.

TitleType III-A CRISPR immunity promotes mutagenesis of staphylococci.
Publication TypeJournal Article
Year of Publication2021
AuthorsMo CY, Mathai J, Rostøl JT, Varble A, Banh DV, Marraffini LA
JournalNature
Date Published2021 Apr 07
ISSN1476-4687
Abstract

Horizontal gene transfer and mutation are the two major drivers of microbial evolution that enable bacteria to adapt to fluctuating environmental stressors. Clustered, regularly interspaced, short palindromic repeats (CRISPR) systems use RNA-guided nucleases to direct sequence-specific destruction of the genomes of mobile genetic elements that mediate horizontal gene transfer, such as conjugative plasmids and bacteriophages, thus limiting the extent to which bacteria can evolve by this mechanism. A subset of CRISPR systems also exhibit non-specific degradation of DNA; however, whether and how this feature affects the host has not yet been examined. Here we show that the non-specific DNase activity of the staphylococcal type III-A CRISPR-Cas system increases mutations in the host and accelerates the generation of antibiotic resistance in Staphylococcus aureus and Staphylococcus epidermidis. These mutations require the induction of the SOS response to DNA damage and display a distinct pattern. Our results demonstrate that by differentially affecting both mechanisms that generate genetic diversity, type III-A CRISPR systems can modulate the evolution of the bacterial host.

DOI10.1038/s41586-021-03440-3
Alternate JournalNature
PubMed ID33828299

Person Type: